Hedges have been a part of gardening for centuries, and their designs have been modernized while maintaining their authentic ...

Drugmaker Eli Lilly (NYSE: LLY) hasn't been exempt from the recent market pullback, but its stock shot higher following the announcement that its newest GLP-1 drug had successfully completed the ...

"Be mindful about what you're sharing, because once it's online, it's online forever," says Lilly Sabri. The fitness influencer, who has six million followers on YouTube, has urged fans to heed ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced success Thursday of its Phase 3 clinical trial for a once-daily GLP-1 pill — an oral form of the blockbuster medication used for ...

Eli Lilly’s new obesity and diabetes pill has shown it can lower blood sugar and aid weight loss in a late-stage trial, sending shares in the US drugmaker up nearly 15 per cent in Wall Street ...

Add articles to your saved list and come back to them any time. Pharmaceutical company Eli Lilly said its experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood ...

Lilly should be the market leader in diabetes and obesity within the next five years. The company is also poised to be a major player in several other indications. Lilly's prospects of becoming ...

Results of the Lilly-funded study provide a promising first look. Diabetics given the pill called orforglipron lost 16 pounds, or 7.9% of their body weight, over a 40-week period.

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Eli Lilly’s new obesity and diabetes pill has shown it can lower blood sugar and aid weight loss in a ...

Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

Eli Lilly's oral GLP-1 drug orforglipron showed strong Phase 3 results with 7.9% weight loss and good tolerability, establishing leadership in obesity treatment. Orforglipron offers advantages ...